These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 29050068
1. [Diagnostic and prognostic roles of loss of CIC protein expression in oligodendroglial tumors]. Liu CC, Zhang LY, Wang LM, Wang DD, Fu YJ, Cai YN, Lu DH, Piao YS. Zhonghua Bing Li Xue Za Zhi; 2017 Oct 08; 46(10):679-683. PubMed ID: 29050068 [Abstract] [Full Text] [Related]
8. Regional specificity of 1p/19q co-deletion combined with radiological features for predicting the survival outcomes of anaplastic oligodendroglial tumor patients. Wang K, Wang Y, Fan X, Li Y, Liu X, Wang J, Ai L, Dai J, Jiang T. J Neurooncol; 2018 Feb 08; 136(3):523-531. PubMed ID: 29230668 [Abstract] [Full Text] [Related]
9. Clinical significance of chromosome 1p/19q loss of heterozygosity and Sox17 expression in oligodendrogliomas. Li J, Miao N, Liu M, Cui W, Liu X, Li X, Shi X, Qing S, Ma Y, Zhang W, Biekemituofu H. Int J Clin Exp Pathol; 2014 Feb 08; 7(12):8609-15. PubMed ID: 25674225 [Abstract] [Full Text] [Related]
11. Co-polysomy of chromosome 1q and 19p predicts worse prognosis in 1p/19q codeleted oligodendroglial tumors: FISH analysis of 148 consecutive cases. Ren X, Jiang H, Cui X, Cui Y, Ma J, Jiang Z, Sui D, Lin S. Neuro Oncol; 2013 Sep 08; 15(9):1244-50. PubMed ID: 23861470 [Abstract] [Full Text] [Related]
13. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179 [Abstract] [Full Text] [Related]
14. High Carbonic Anhydrase-9 Expression Identifies a Subset of 1p/19q Co-Deletion and Favorable Prognosis in Oligodendroglioma. Sathornsumetee S, Cheunsuchon P, Sangruchi T. World Neurosurg; 2016 Jul 01; 91():518-523.e1. PubMed ID: 26960282 [Abstract] [Full Text] [Related]
16. Eighty percent survival rate at 15 years for 1p/19q co-deleted oligodendroglioma treated with upfront chemotherapy irrespective of tumor grade. Iwadate Y, Matsutani T, Hara A, Hirono S, Ikegami S, Kobayashi M, Ito D, Kawauchi D, Horiguchi K, Tamiya A, Higuchi Y. J Neurooncol; 2019 Jan 01; 141(1):205-211. PubMed ID: 30565028 [Abstract] [Full Text] [Related]
17. A "weighted" fluorescence in situ hybridization strengthens the favorable prognostic value of 1p/19q codeletion in pure and mixed oligodendroglial tumors. Senetta R, Verdun di Cantogno L, Chiusa L, Castellano I, Gugliotta P, Sapino A, Cassoni P. J Neuropathol Exp Neurol; 2013 May 01; 72(5):432-41. PubMed ID: 23584201 [Abstract] [Full Text] [Related]
18. Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J, Funada N, Fujimaki T, Hojo S, Kubo O, Ide T, Usui M, Ochiai C, Ito S, Takahashi H, Mukasa A, Asai A, Kirino T. Clin Cancer Res; 2002 Jan 01; 8(1):196-201. PubMed ID: 11801559 [Abstract] [Full Text] [Related]
19. Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletion. Pai T, Epari S, Desai S, Wadile A, Gupta T, Goda JS, Moiyadi A, Shetty P, Kane S, Jalali R. Neurol India; 2017 Jan 01; 65(1):113-120. PubMed ID: 28084254 [Abstract] [Full Text] [Related]
20. Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors. Chen H, Thomas C, Munoz FA, Alexandrescu S, Horbinski CM, Olar A, McGuone D, Camelo-Piragua S, Wang L, Pentsova E, Phillips J, Aldape K, Chen W, Iafrate AJ, Chi AS, Zagzag D, Golfinos JG, Placantonakis DG, Rosenblum M, Ohman-Strickland P, Hameed M, Snuderl M. Neuro Oncol; 2019 Sep 06; 21(9):1164-1174. PubMed ID: 31140557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]